These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14084574)

  • 1. COMBINED FIBRINOLYSIN AND ANTICOAGULANT THERAPY OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM.
    MAYER GA; DORSEY DM; MAXIMIN TH
    Appl Ther; 1963 Dec; 5():1072-82. PubMed ID: 14084574
    [No Abstract]   [Full Text] [Related]  

  • 2. [EXPERIENCE IN THE CLINICAL USE OF FIBRINOLYSIN].
    PANCHENKO VM; ANDREENKO GV
    Ter Arkh; 1964 Jan; 36():43-51. PubMed ID: 14149444
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMBINED FIBRINOLYSIN AND HEPARIN THERAPY OF VASCULAR THROMBOSIS].
    MIASNIKOV AL; KUDRIASHOV BA; CHASOV EI; ANDREENKO GV
    Kardiologiia; 1964; 4():3-8. PubMed ID: 14152588
    [No Abstract]   [Full Text] [Related]  

  • 4. [EXPERIENCES ABROAD AND IN HUNGARY IN THE ANTICOAGULANT TREATMENT OF DEEP VEIN THROMBOSIS AND THROMBOPHLEBITIS].
    BUGAR MESZAROS K
    Orv Hetil; 1964 Nov; 105():2219-23. PubMed ID: 14232611
    [No Abstract]   [Full Text] [Related]  

  • 5. Experiences with venous thrombosis and pulmonary embolism, with special reference to anticoagulant therapy.
    VANDER VEER JB; KUO PT; MARSHALL DS
    Am J Med Sci; 1950 Feb; 219(2):117-26. PubMed ID: 15403156
    [No Abstract]   [Full Text] [Related]  

  • 6. [ROLE OF ANTICOAGULANT THERAPY IN THE PREVENTION OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM].
    KNEZEVIC S
    Med Glas; 1964 Aug; 18():217-9. PubMed ID: 14271404
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of venous thrombosis with anticoagulants; review of 1135 cases.
    MARKS J; TRUSCOTT BM; WITHYCOMBE JF
    Lancet; 1954 Oct; 267(6842):787-91. PubMed ID: 13213039
    [No Abstract]   [Full Text] [Related]  

  • 8. [TREATMENT OF VENOUS THROMBOSIS].
    BEAUMONT JL
    Cah Coll Med Hop Paris; 1964 Mar; 5():184-90. PubMed ID: 14144536
    [No Abstract]   [Full Text] [Related]  

  • 9. DVT and pulmonary embolism: Part II. Treatment and prevention.
    Ramzi DW; Leeper KV
    Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [THE TREATMENT OF VENOUS THROMBOSIS].
    APARICIO
    J Med Bord; 1964 Mar; 141():443-4. PubMed ID: 14143016
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.
    Campbell IA; Bentley DP; Prescott RJ; Routledge PA; Shetty HG; Williamson IJ
    BMJ; 2007 Mar; 334(7595):674. PubMed ID: 17289685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Strategies for utilization of anticoagulants in pulmonary embolism].
    Fartoukh M; Simonneau G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):949-60. PubMed ID: 10907444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant treatment of postoperative venous thrombosis and pulmonary embolism.
    Evans JA; Dee JF
    N Engl J Med; 1948 Jan; 238(1):1-5. PubMed ID: 18919229
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs. unfractionated heparin.
    Riess H; Becker LK; Melzer N; Harenberg J
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):838-44. PubMed ID: 25004024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE EFFECT OF COMMERCIAL THROMBOLYTIC AGENTS ON EXPERIMENTAL VENOUS THROMBOSIS.
    RUDDICK DW; ROBERTSON HR; MERSEREAU WA
    J Trauma; 1964 Sep; 4():677-81. PubMed ID: 14208792
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMPARISON OF A FIBRINOLYSIN AND HEPARIN ON INDUCED VENOUS THROMBOSIS AND THROMBOLYSIS.
    WILLIAMS RD; KARAFFA F
    Surg Gynecol Obstet; 1965 Aug; 121():309-12. PubMed ID: 14320378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.